The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension.

Autor: T, Abrahamsen Christian, C, Barone Frank, G, Campbell Wallace, H, Nelson Allen, C, Contino Lisa, A, Pullen Mark, T, Grygielko Eugene, M, Edwards Richard, J, Laping Nicholas, P, Brooks David

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; April 2002, Vol. 301 Issue: 1 p21-8, 8p